Related Experiment Video

Updated: May 13, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Pharmacological inhibition of glycogen synthase kinase 3 regulates T cell development in vitro

Jan-Hendrik Schroeder1, Lewis S Bell, Michelle L Janas

  • 1Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.

Plos One
|March 26, 2013
PubMed

Insights

Inhibiting Glycogen Synthase Kinase 3 (GSK3) promotes thymocyte development during beta-selection, even without key signals. This finding suggests GSK3 inactivation is crucial for T cell maturation and may enable new in vitro culture systems.

Area of Science:

  • Immunology
  • Cell Biology
  • Developmental Biology

Background:

  • T cell development in the thymus involves critical checkpoints, including beta-selection at the DN3 stage.
  • Beta-selection requires signaling through the pre-T cell receptor (TCR), Notch1, and CXCL12, converging on pathways like PI3K.
  • The role of Glycogen Synthase Kinase 3 (GSK3) in beta-selection, despite its known regulation by PI3K, remains uncharacterized.

Purpose of the Study:

  • To investigate the role of GSK3 in the beta-selection process during T cell development.
  • To determine if inhibiting GSK3 can influence DN3 thymocyte progression and differentiation.

Main Methods:

  • Utilized the synthetic compound CHIR99021 to inhibit GSK3 activity in DN3 thymocytes.
  • Assessed thymocyte differentiation and progression in the presence and absence of pre-TCR, Notch1, and CXCL12 signaling.
  • Examined the effects of GSK3 inhibition on IL-7-mediated signaling and thymocyte recovery.

Main Results:

  • Inhibition of GSK3 by CHIR99021 promoted the developmental progression of DN3 thymocytes.
  • CHIR99021 facilitated thymocyte differentiation independently of pre-TCR, Notch1, or CXCL12 signaling.
  • GSK3 inhibition counteracted IL-7-mediated inhibition of DP thymocyte differentiation and enhanced IL-7-promoted cell recovery.

Conclusions:

  • Inactivation of GSK3 plays a significant role in promoting T cell development during beta-selection.
  • These findings suggest GSK3 inhibition as a potential strategy for developing novel in vitro stromal cell-free culture systems for thymocyte development.
  • This research provides a new platform for screening regulators of thymocyte proliferation, differentiation, and apoptosis.

More Related Videos

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...